Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bloch

Showing results (541-550 of 559) with videos related to

Pageof 56
Sort By:
Vox Sanguinis|March 9, 2022
International Society of Blood Transfusion survey of experiences of blood banks and transfusion services during the COVID-19 pandemicArwa Z Al-Riyami, Thierry Burnouf, Erica M Wood, et al.
Medrxiv : the Preprint Server for Health Sciences|February 24, 2023
Early Treatment, Inflammation and Post-COVID ConditionsKelly A Gebo, Sonya L Heath, Yuriko Fukuta, et al.
Mbio|December 14, 2023
Erratum for Gebo et al., "Early antibody treatment, inflammation, and risk of post-COVID conditions"Kelly A Gebo, Sonya L Heath, Yuriko Fukuta, et al.
Mbio|September 19, 2023
Early antibody treatment, inflammation, and risk of post-COVID conditionsKelly A Gebo, Sonya L Heath, Yuriko Fukuta, et al.
The Lancet. Microbe|September 2, 2023
Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort studyXianming Zhu, Kelly A Gebo, Alison G Abraham, et al.
Microbiology Spectrum|November 27, 2023
COVID-19 convalescent plasma therapy decreases inflammatory cytokines: a randomized controlled trialFeben Habtehyimer, Xianming Zhu, Andrew D Redd, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 17, 2022
Transfusing Convalescent Plasma as Post-Exposure Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Double-Blinded, Phase 2 Randomized, Controlled TrialShmuel Shoham, Evan M Bloch, Arturo Casadevall, et al.
Medrxiv : the Preprint Server for Health Sciences|December 21, 2021
Randomized controlled trial transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infectionShmuel Shoham, Evan M Bloch, Arturo Casadevall, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|October 20, 2023
Rates Among Hospitalized Patients With COVID-19 Treated With Convalescent Plasma: A Systematic Review and Meta-AnalysisJonathon W Senefeld, Ellen K Gorman, Patrick W Johnson, et al.
Transfusion|August 3, 2023
Transfusion reactions associated with COVID-19 convalescent plasma in outpatient clinical trialsMoises A Huaman, Jay S Raval, James H Paxton, et al.
Pageof 56

Showing results (541-550 of 559) with videos related to

Sort By:
Pageof 56
Vox Sanguinis|March 9, 2022
International Society of Blood Transfusion survey of experiences of blood banks and transfusion services during the COVID-19 pandemicArwa Z Al-Riyami, Thierry Burnouf, Erica M Wood, et al.
Medrxiv : the Preprint Server for Health Sciences|February 24, 2023
Early Treatment, Inflammation and Post-COVID ConditionsKelly A Gebo, Sonya L Heath, Yuriko Fukuta, et al.
Mbio|December 14, 2023
Erratum for Gebo et al., "Early antibody treatment, inflammation, and risk of post-COVID conditions"Kelly A Gebo, Sonya L Heath, Yuriko Fukuta, et al.
Mbio|September 19, 2023
Early antibody treatment, inflammation, and risk of post-COVID conditionsKelly A Gebo, Sonya L Heath, Yuriko Fukuta, et al.
The Lancet. Microbe|September 2, 2023
Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort studyXianming Zhu, Kelly A Gebo, Alison G Abraham, et al.
Microbiology Spectrum|November 27, 2023
COVID-19 convalescent plasma therapy decreases inflammatory cytokines: a randomized controlled trialFeben Habtehyimer, Xianming Zhu, Andrew D Redd, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 17, 2022
Transfusing Convalescent Plasma as Post-Exposure Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Double-Blinded, Phase 2 Randomized, Controlled TrialShmuel Shoham, Evan M Bloch, Arturo Casadevall, et al.
Medrxiv : the Preprint Server for Health Sciences|December 21, 2021
Randomized controlled trial transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infectionShmuel Shoham, Evan M Bloch, Arturo Casadevall, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|October 20, 2023
Rates Among Hospitalized Patients With COVID-19 Treated With Convalescent Plasma: A Systematic Review and Meta-AnalysisJonathon W Senefeld, Ellen K Gorman, Patrick W Johnson, et al.
Transfusion|August 3, 2023
Transfusion reactions associated with COVID-19 convalescent plasma in outpatient clinical trialsMoises A Huaman, Jay S Raval, James H Paxton, et al.
Pageof 56